Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors

BACKGROUND: There is ongoing search for new noninvasive biomarkers to improve management of patients with hepatocellular carcinoma (HCC). Studies, mostly from the Asian-Pacific region, demonstrated differential expression of liver-specific microRNA-122 (miR-122) in tissue as well as in sera of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Franck, Martin, Schütte, Kerstin, Malfertheiner, Peter, Link, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952302/
https://www.ncbi.nlm.nih.gov/pubmed/31933516
http://dx.doi.org/10.3748/wjg.v26.i1.86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952302/
https://www.ncbi.nlm.nih.gov/pubmed/31933516
http://dx.doi.org/10.3748/wjg.v26.i1.86

Ejemplares similares